GlassScriptPhysician profile
Radhika Kainthla
NPI 1912263781
$938.21
in general payments reported to CMS, 2019-2025
15 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.13 · 2020: $33.75 · 2023: $162 · 2024: $369 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.33 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $172.67 | 2023-2025 | Xospata, Vyloy, Padcev |
| Janssen Scientific Affairs, LLC | $150.00 | 2024 | Talvey |
| Incyte Corporation | $145.85 | 2023-2025 | Monjuvi, Jakafi, Pemazyre |
| Merck Sharp & Dohme LLC | $119.94 | 2019-2025 | Keytruda, Keytruda Qlex |
| Bayer Healthcare Pharmaceuticals INC. | $78.61 | 2020-2023 | |
| Deciphera Pharmaceuticals INC. | $54.94 | 2025 | Romvimza, Qinlock |
| Takeda Pharmaceuticals U.S.A., INC. | $41.85 | 2024-2025 | Iclusig, Ninlaro |
| Exelixis INC. | $37.92 | 2025 | Cabometyx |
| Emmaus Medical, INC. | $34.47 | 2023-2024 | Endari |
| Geron Corporation | $23.11 | 2025 | Rytelo |
| Intera Oncology, INC | $22.09 | 2023 | Intera 3000 Implantable Pump |
| Abbvie INC. | $16.53 | 2024 | |
| Foundation Medicine, INC. | $14.21 | 2023 | |
| Array Biopharma INC | $14.04 | 2025 | Xalkori, Braftovi, Mektovi |
| Daiichi Sankyo INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Radhika Kainthla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.